Cargando…
Phlorizin Exerts Direct Protective Effects on Palmitic Acid (PA)-Induced Endothelial Dysfunction by Activating the PI3K/AKT/eNOS Signaling Pathway and Increasing the Levels of Nitric Oxide (NO)
BACKGROUND: Sodium glucose transporter-2 inhibitors are the newest antidiabetic drugs that seem to be cardioprotective and can prevent type 2 diabetes in patients with high cardiovascular risks. Previous clinical trials have shown that these inhibitors can alleviate endothelial dysfunction, but the...
Autores principales: | Li, Chun-Ying, Wang, Liang-Xue, Dong, Si-Si, Hong, Ying, Zhou, Xin-He, Zheng, Wen-Wen, Zheng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771185/ https://www.ncbi.nlm.nih.gov/pubmed/29307883 http://dx.doi.org/10.12659/MSMBR.907775 |
Ejemplares similares
-
Icariside Ⅱ Attenuates Palmitic Acid-Induced Endothelial Dysfunction Through SRPK1-Akt-eNOS Signaling Pathway
por: Gu, Yang-Yang, et al.
Publicado: (2022) -
Ang (1–7) Protects Islet Endothelial Cells from Palmitate-Induced Apoptosis by AKT, eNOS, p38 MAPK, and JNK Pathways
por: Yuan, Li, et al.
Publicado: (2014) -
Extensive Ethnogenomic Diversity of Endothelial Nitric Oxide Synthase (eNOS) Polymorphisms
por: Thomas, Bolaji N., et al.
Publicado: (2013) -
κ-Opioid receptor stimulation reduces palmitate-induced apoptosis via Akt/eNOS signaling pathway
por: Cui, Yan, et al.
Publicado: (2019) -
Endothelial nitric oxide synthase (eNOS) variants in cardiovascular disease: pharmacogenomic implications
por: Bhanoori, Manjula
Publicado: (2011)